Daphne Zohar

Daphne Zohar is the Founder and Managing Partner of PureTech Ventures, a Boston-based life sciences venture firm focused on translating academic innovation into commercial success. A successful entrepreneur, Zohar created PureTech and assembled a leading team to help implement her vision for the firm. She sits on the boards of Solace Pharmaceuticals (where she was founding CEO), Follica Inc (founding CEO), Enlight Biosciences, Endra, and Satori Pharmaceuticals (founding CEO). Zohar was named one of the world's top young innovators who will shape the future of technology by MIT's Technology Review magazine and one of the top "40 under 40" by the Boston Business Journal.

Recent posts and comments

• Commenting on: Gone Today, Hair Tomorrow—Follica Raises Funds to Begin Human Trial of Baldness Treatment

  Daphne said: Thanks for all the thoughtful comments and feedback. I would like to provide some perspective regarding our silence. Even... Read more »

• Mixed Feelings About “The Funded”

  Am interested to hear what people think about this website (www.thefunded.com) where entrepreneurs rank venture funds. I like the concept of shifting the power dynamic and keeping venture funds... Read more »

• Patent Reform Will Stifle Innovation

  I believe the proposed patent reform act would stifle innovation, which already has many hurdles to overcome, particularly in the earliest stages (when foundational patents are filed). To arbitrarily limit damages... Read more »